To the Editor: Forder et al conveyed that trials without allocation concealment have the potential to mislead.1 However, it is not true in any meaningful sense that “Without exception, allocation concealment is achievable in all randomised clinical trials. In contrast, it is not always possible to blind people to study treatments received.” Rather, “Masking may be defined as either the process (researchers not revealing treatment codes until the database is locked) or the result (complete ignorance of all trial participants as to which patients received which treatments). A masking claim indicates only the former . . . If masking is possible only some of the time, then clearly reference is being made to the result, and not the process. To be fair, then, one would have to ask if the result of allocation concealment is always possible . . . only the process of allocation concealment, but not its result, can be ensured.”2
Publication of your online response is subject to the Medical Journal of Australia's editorial discretion. You will be notified by email within five working days should your response be accepted.